GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 3,906 | 3,091 | 3,168 | 3,122 | 3,621 |
| Operating Income | -3,906 | -3,091 | -3,168 | -3,122 | -3,621 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 196 | 825 | 206 | 706 | 1,630 |
| Pre-tax Income | -3,710 | -2,266 | -2,962 | -2,416 | -1,992 |
| Net Income Continuous | -3,710 | -2,266 | -2,962 | -2,416 | -1,992 |
| Net Income | $-3,710 | $-2,266 | $-2,962 | $-2,416 | $-1,992 |
| EPS Basic Total Ops | -2.17 | -1.64 | -2.17 | -1.77 | -1.49 |
| EPS Basic Continuous Ops | -2.17 | -1.64 | -2.17 | -1.77 | -1.49 |
| EPS Diluted Total Ops | -2.17 | -1.64 | -2.17 | -1.77 | -1.49 |
| EPS Diluted Continuous Ops | -2.17 | -1.64 | -2.17 | -1.77 | -1.49 |
| EPS Diluted Before Non-Recurring Items | -2.24 | -2.12 | N/A | N/A | N/A |
| EBITDA(a) | $-3,906 | $-3,091 | $-3,168 | $-3,122 | $-3,621 |